Reginster J Y, Richy F, Bruyere O
Service de Santé Publique, Epidémiologie et Economie de la Santé.
Rev Med Liege. 2006 Mar;61(3):169-72.
Glucosamine is widely used as a symptom-modifying drug in osteoarthritis. New clinical trials, from Europe and the United-States bring some clarification regarding the optimal formulation and doses to be used in knee osteoarthritis. Their results are supported by new pharmacokinetic and preclinical studies, explaining the mode of action of glucosamine in osteoarthritis.
